Hualan Biological Bacterin Inc. (301207.SZ)
CNY 18.51
(0.16%)
CNY 18.51
(0.16%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.12 Billion CNY | 28.19% |
| 2022 | 1.6 Billion CNY | -0.05% |
| 2021 | 1.6 Billion CNY | -25.8% |
| 2020 | 2.16 Billion CNY | 144.19% |
| 2019 | 887.98 Million CNY | 31.38% |
| 2018 | 675.86 Million CNY | 242.98% |
| 2017 | 197.05 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 744.29 Million CNY | 1926.7% |
| 2024 Q1 | 30.81 Million CNY | -94.77% |
| 2024 Q2 | -41.01 Million CNY | -233.08% |
| 2023 Q1 | 145.08 Million CNY | -38.76% |
| 2023 FY | 2.06 Billion CNY | 28.19% |
| 2023 Q4 | 588.95 Million CNY | -56.95% |
| 2023 Q3 | 1.36 Billion CNY | 22509.19% |
| 2023 Q2 | 6.05 Million CNY | -95.83% |
| 2022 Q3 | 433.27 Million CNY | -53.09% |
| 2022 Q2 | 923.64 Million CNY | 6339.18% |
| 2022 Q1 | 14.34 Million CNY | -96.22% |
| 2022 FY | 1.6 Billion CNY | -0.05% |
| 2022 Q4 | 236.92 Million CNY | -45.32% |
| 2021 Q1 | 1 Million CNY | -99.92% |
| 2021 Q4 | 379.45 Million CNY | -68.89% |
| 2021 Q3 | 1.21 Billion CNY | 146364.9% |
| 2021 Q2 | -833.86 Thousand CNY | -183.27% |
| 2021 FY | 1.6 Billion CNY | -25.8% |
| 2020 FY | 2.16 Billion CNY | 144.19% |
| 2020 Q4 | 1.18 Billion CNY | 20.04% |
| 2020 Q3 | 988.07 Million CNY | 13033.68% |
| 2020 Q2 | -7.63 Million CNY | 12.58% |
| 2020 Q1 | -8.73 Million CNY | 0.0% |
| 2019 FY | 887.98 Million CNY | 31.38% |
| 2018 FY | 675.86 Million CNY | 242.98% |
| 2017 FY | 197.05 Million CNY | 0.0% |